Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

Published:2018-08-31 Issue:3 Volume:68 Page:1174-1188
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ponsioen Cyriel Y.¹,Lindor Keith D.²,Mehta Ruby³,Dimick-Santos Lara³

Affiliation:

1. Department of Gastroenterology & Hepatology; Academic Medical Center; Amsterdam The Netherlands

2. College of Health Solutions; Arizona State University; Phoenix AZ

3. Division of Gastroenterology and Inborn Errors Products; United States Food and Drug Administration; Silver Spring MD

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29882/fullpdf

Reference78 articles.

1. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review;Boonstra;JHepatol,2012

2. Diagnosis and management of primary sclerosing cholangitis;Chapman;Hepatology,2009

3. EASL Clinical Practice Guidelines: management of cholestatic liver diseases;European Association for the Study of the Liver;JHepatol,2009

4. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature;Björnsson;Hepatology,2007

5. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis;Cell Reports Medicine;2024-07

2. Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial;BMJ Open;2024-06

3. Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis;BMJ Open;2024-06

4. Patient-focused drug development in primary sclerosing cholangitis: Insights on patient priorities and involvement in clinical trials;Hepatology Communications;2024-05-10

5. Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study;Alimentary Pharmacology & Therapeutics;2024-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3